Dyadic Tailored Home-Based Activity Program for Mild-to-Moderate Dementia Patients Post-Discharge
Development and Efficacy of a Dyadic Tailored Home-Based Activity Program for Mild-to-Moderate Dementia With Behavioral and Psychological Symptoms Post-Discharge: A Randomized Controlled Trial
1 other identifier
interventional
55
0 countries
N/A
Brief Summary
This interventional study aims to evaluate the efficacy of a dyadic tailored home-based activity program in managing behavioral and psychological symptoms of dementia (BPSD) among home-dwelling people living with mild-to-moderate dementia post-discharge. The main question it aims to answer is: Does the dyadic tailored home-based activity program significantly reduce BPSD in individuals with mild-to-moderate dementia after hospital discharge? Researchers will compare people living with mild to moderate dementia who are receiving routine care to see if the dyadic tailored home-based activity program is effective for BPSD. Participants will:
- 1.During hospitalization: People living with mild to moderate dementia and their caregivers receive health education on managing behavioral and psychological symptoms of dementia (BPSD); Participating activity sessions to assess individual preferences and functional activity capabilities, followed by co-designing a dyadic tailored home-based activity program.
- 2.After discharge: People living with mild to moderate dementia and their caregivers jointly receive a 12-week dyadic tailored home-based activity intervention at home.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2025
CompletedStudy Start
First participant enrolled
July 20, 2025
CompletedFirst Posted
Study publicly available on registry
July 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
July 23, 2025
July 1, 2025
12 months
July 6, 2025
July 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Behavioral and Psychological Symptoms of Dementia
Assessment using the Neuropsychiatric Inventory (NPI) yields scores ranging from 0 to 144, with higher scores indicating more severe neuropsychiatric symptoms
Baseline and post-intervention (at the end of week 12)
Caregiver Distress of Behavioral and Psychological Symptoms of Dementia
Assessment using the caregiver distress section of the Neuropsychiatric Inventory (NPI) yields scores ranging from 0 to 60, with higher scores indicating greater caregiver distress levels
Baseline and post-intervention (at the end of week 12)
Secondary Outcomes (16)
Cognitive Function of Dementia Patients
Baseline and post-intervention (at the end of week 12)
Activities of Daily Living of Dementia Patients
Baseline and post-intervention (at the end of week 12)
Apathy of Dementia Patients
Baseline and post-intervention (at the end of week 12)
Agitation of Dementia Patients
Baseline and post-intervention (at the end of week 12)
Quality of Life in Dementia
Baseline and post-intervention (at the end of week 12)
- +11 more secondary outcomes
Other Outcomes (3)
Number of caregivers with varying levels of satisfaction towards the intervention
Post-intervention (at the end of week 12)
Number of dementia patients with varying levels of satisfaction towards the intervention
Post-intervention (at the end of week 12)
Number of completed activity intervention sessions for dementia patients
Post-intervention (at the end of week 12)
Study Arms (2)
Dyadic tailored home-based activity program intervention
EXPERIMENTAL(1) During hospitalization, caregivers receive health education on managing behavioral and psychological symptoms of dementia. Patient-caregiver dyads participate in structured ward activities to assess activity preferences and capabilities, forming the basis for co-developing individualized home activity plans with training for caregivers. (2) A customized home activity kit is provided at discharge. (3) Post-discharge, a 12-week tailored home intervention is implemented, using a patient-centered model with caregiver support. Caregivers record participation and behavioral responses, which inform dynamic adjustments to activity content, difficulty, and methods.
Routine care
ACTIVE COMPARATORParticipants will receive routine care consisting of standard hospitalization treatment, basic caregiver education on behavioral and psychological symptoms of dementia (BPSD), routine discharge instructions (including general home activity recommendations without personalized intervention assessment, planning or implementation), and routine post-discharge follow-up for 12 weeks.
Interventions
1. During hospitalization, caregivers receive health education on managing behavioral and psychological symptoms of dementia. Patient-caregiver dyads participate in structured ward activities to assess activity preferences and capabilities, forming the basis for co-developing individualized home activity plans with training for caregivers. 2. A customized home activity kit is provided at discharge. 3. Post-discharge, a 12-week tailored home intervention is implemented, using a patient-centered model with caregiver support. Caregivers record participation and behavioral responses, which inform dynamic adjustments to activity content, difficulty, and methods.
Participants will receive routine care consisting of standard hospitalization treatment, basic caregiver education on behavioral and psychological symptoms of dementia (BPSD), routine discharge instructions (including general home activity recommendations without personalized intervention assessment, planning or implementation), and routine post-discharge follow-up for 12 weeks.
Eligibility Criteria
You may qualify if:
- Patients:
- Aged ≥60 years;
- ICD-10 diagnosed dementia with Clinician's Dementia Rating (CDR) scores of 1-2 (mild-to-moderate stage);
- Preserved basic verbal communication capacity;
- Exhibit at least one neuropsychiatric symptom (score ≥1 on any item) in the past month, as assessed by the Neuropsychiatric Inventory (NPI);
- Medically cleared for discharge with planned home-based care;
- Willing to provide written informed consent.
- Caregivers:
- Aged ≥18 years;
- Designated primary caregiver (the individual spends the longest time caring for the patient each day);
- Committed to maintaining home caregiving responsibilities for at least 3 months post-discharge;
- Intact verbal communication skills;
- Possess basic operational proficiency with the WeChat application (capable of independently sending/receiving messages and conducting voice/video calls)
- Willing to provide written informed consent.
You may not qualify if:
- Patients:
- Comorbid severe somatic diseases (e.g., malignant tumors, heart failure, physical disabilities) or psychiatric disorders;
- Severe visual or hearing impairment;
- Dementia caused by the following conditions: Central nervous system diseases (e.g., encephalitis, brain tumors, epilepsy, multiple sclerosis, Parkinson's disease); Nutritional/metabolic disorders (e.g., thyroid dysfunction, vitamin B12/folate deficiency); Substance or alcohol dependence; Other potential etiologies of secondary dementia;
- Severe physical or mental illness, extreme debilitation, long-term bedridden status, end-stage disease (with a life expectancy of less than six months), or an inability to cooperate with or tolerate the study;
- Currently participating in other medical research that may interfere with study outcomes.
- Caregivers:
- Comorbid severe somatic diseases (e.g., malignant tumors, heart failure, physical disabilities) or psychiatric disorders;
- Severe visual or hearing impairment;
- Currently participating in other medical research that may interfere with study outcomes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Graduate Researcher
Study Record Dates
First Submitted
July 6, 2025
First Posted
July 23, 2025
Study Start
July 20, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
July 23, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share